Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 0.7
Power Rank trend -> Falling
Industry: Medical Instruments & Supplies
Follow @stockchartsai on TwitterIn the past 20 trading days, ALGN has been trading in a range between $234.89 and $210.46 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
The AI powered stock chart is in a Red zone currently. We would avoid this stock.
Align Technology Inc $ALGN entered a Red zone 2 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $266.3071, a potential upside of 26.48% from the recent price of 210.55. The stock is trading 59.3% (potential upside) below its 52 week high of $335.40 and 7.37 % (potential downside) above its 52 week low of $196.09 - based on the recent price.
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Invisalign® Palatal Expander System by Align Technology Now Available in Turkey for Skeletal and Dental Expansion in Growing Patients ROTKREUZ, Switzerland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal Expander System has been approved by the Turkish Medicines and Medical Device Agency (TMMDA) and is now commercially available in Turk. Source: Business Wire Mon, 10 Feb 2025 08:30:00 -0500 Sentiment: Neutral |
ALGN Q4 Earnings Top Estimates, Revenues Miss, Stock Falls Align Technology reports fourth-quarter 2024 revenue growth. This can be mostly attributed to the robust performance of the Imaging Systems & CAD/CAM Services business segment. Source: Zacks Investment Research Thu, 06 Feb 2025 10:51:22 -0500 Sentiment: Neutral |
Align: Q4 Foreign Exchange Challenges Align Technology (ALGN 0.75%), known for its Invisalign clear aligners and digital dental systems, announced its fourth-quarter 2024 results on Feb. 5, 2025. The earnings release highlighted stable performance amid currency and demand challenges. Source: The Motley Fool Wed, 05 Feb 2025 19:10:56 -0500 Sentiment: Negative |
Align Technology (ALGN) Reports Q4 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. Source: Zacks Investment Research Wed, 05 Feb 2025 19:01:22 -0500 Sentiment: Positive |
Align Technology (ALGN) Beats Q4 Earnings Estimates Align Technology (ALGN) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.42 per share a year ago. Source: Zacks Investment Research Wed, 05 Feb 2025 18:25:27 -0500 Sentiment: Positive |
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.